Principal Healthcare Innovators ETF

Rentabilität für sechs Monate: 0%
Industrie: Health & Biotech Equities

Kategorie	Aktie, %	Menge
Healthcare	99.53953	212

Austausch	Aktie, %	Menge
NASDAQ	97.17	206
New York Stock Exchange	2.83	6

Teilen nach Land

Land	Menge	Unternehmen
United States	175	Gilead Sciences (aktie - 8.5%) Amgen (aktie - 8.09%) Regeneron (aktie - 7.73%) Vertex (aktie - 7.5%) Alnylam Pharmaceuticals, Inc. (aktie - 3.41%) Biogen (aktie - 2.82%) Moderna (aktie - 2.45%) Illumina (aktie - 2.03%) Summit Therapeutics Inc. (aktie - 1.71%) United Therapeutics Corporation (aktie - 1.52%) Viatris (aktie - 1.32%) BioMarin Pharmaceutical (aktie - 1.31%) Vaxcyte, Inc. (aktie - 1.25%) Insmed Incorporated (aktie - 1.24%) Incyte (aktie - 1.23%) Royalty Pharma plc (aktie - 1.2%) Sarepta Therapeutics, Inc. (aktie - 1.18%) Neurocrine Biosciences (aktie - 1.16%) Medpace Holdings, Inc. (aktie - 1.1%) Intra-Cellular Therapies, Inc. (aktie - 0.795%) Revolution Medicines, Inc. (aktie - 0.7374%) Exelixis (aktie - 0.7312%) Halozyme Therapeutics, Inc. (aktie - 0.7281%) Nuvalent, Inc. (aktie - 0.6195%) Cytokinetics, Incorporated (aktie - 0.6138%) Ionis Pharmaceuticals (aktie - 0.61%) Blueprint Medicines Corporation (aktie - 0.5634%) Ultragenyx Pharmaceutical Inc. (aktie - 0.5253%) Krystal Biotech, Inc. (aktie - 0.5149%) Avidity Biosciences, Inc. (aktie - 0.5054%) Madrigal Pharmaceuticals, Inc. (aktie - 0.4918%) BridgeBio Pharma, Inc. (aktie - 0.4855%) ADMA Biologics, Inc. (aktie - 0.4548%) Arcellx, Inc. (aktie - 0.4496%) Axsome Therapeutics, Inc. (aktie - 0.4469%) Denali Therapeutics Inc. (aktie - 0.4277%) Immunovant, Inc. (aktie - 0.4142%) Crinetics Pharmaceuticals, Inc. (aktie - 0.4127%) Legend Biotech Corporation (aktie - 0.3846%) Apellis Pharmaceuticals, Inc. (aktie - 0.3828%) Dyne Therapeutics, Inc. (aktie - 0.3564%) Amicus Therapeutics, Inc. (aktie - 0.3244%) Rhythm Pharmaceuticals, Inc. (aktie - 0.3123%) Kymera Therapeutics, Inc. (aktie - 0.312%) Iovance Biotherapeutics, Inc. (aktie - 0.2989%) Guardant Health, Inc. (aktie - 0.2979%) IDEAYA Biosciences, Inc. (aktie - 0.2869%) Geron Corporation (aktie - 0.2763%) PTC Therapeutics, Inc. (aktie - 0.2726%) Protagonist Therapeutics, Inc. (aktie - 0.2693%) ACADIA Pharmaceuticals Inc. (aktie - 0.2649%) Twist Bioscience Corporation (aktie - 0.2623%) Veracyte, Inc. (aktie - 0.2583%) Edgewise Therapeutics, Inc. (aktie - 0.2578%) Agios Pharmaceuticals, Inc. (aktie - 0.2564%) Apogee Therapeutics, Inc. Common Stock (aktie - 0.2549%) Janux Therapeutics, Inc. (aktie - 0.2525%) Arrowhead Pharmaceuticals, Inc. (aktie - 0.2506%) SpringWorks Therapeutics, Inc. (aktie - 0.2471%) Myriad Genetics, Inc. (aktie - 0.2427%) Structure Therapeutics Inc. (aktie - 0.2423%) ImmunityBio, Inc. (aktie - 0.2362%) Amphastar Pharmaceuticals, Inc. (aktie - 0.2333%) Vera Therapeutics, Inc. (aktie - 0.227%) Vericel Corporation (aktie - 0.2247%) Harmony Biosciences Holdings, Inc. (aktie - 0.217%) Intellia Therapeutics, Inc. (aktie - 0.2156%) Beam Therapeutics Inc. (aktie - 0.2048%) Keros Therapeutics, Inc. (aktie - 0.2031%) Novavax, Inc. (aktie - 0.2005%) Akero Therapeutics, Inc. (aktie - 0.1884%) Ligand Pharmaceuticals Incorporated (aktie - 0.1841%) Recursion Pharmaceuticals, Inc. (aktie - 0.1815%) Mirum Pharmaceuticals, Inc. (aktie - 0.1795%) Rocket Pharmaceuticals, Inc. (aktie - 0.1776%) MannKind Corporation (aktie - 0.1743%) Supernus Pharmaceuticals, Inc. (aktie - 0.1714%) Arvinas, Inc. (aktie - 0.1701%) BioCryst Pharmaceuticals, Inc. (aktie - 0.1604%) Nurix Therapeutics, Inc. (aktie - 0.1601%) Kura Oncology, Inc. (aktie - 0.1548%) Harrow Health, Inc. (aktie - 0.1545%) Syndax Pharmaceuticals, Inc. (aktie - 0.1506%) Dynavax Technologies Corporation (aktie - 0.1457%) Day One Biopharmaceuticals, Inc. (aktie - 0.1432%) Ardelyx, Inc. (aktie - 0.1391%) Disc Medicine Opco Inc (aktie - 0.1388%) ARS Pharmaceuticals, Inc. (aktie - 0.1376%) Ocular Therapeutix, Inc. (aktie - 0.1349%) Xencor, Inc. (aktie - 0.1272%) Tarsus Pharmaceuticals, Inc. (aktie - 0.1265%) Collegium Pharmaceutical, Inc. (aktie - 0.124%) Phathom Pharmaceuticals, Inc. (aktie - 0.1221%) ANI Pharmaceuticals (aktie - 0.1221%) Innoviva, Inc. (aktie - 0.1192%) Cogent Biosciences, Inc. (aktie - 0.1166%) Travere Therapeutics, Inc. (aktie - 0.116%) Maravai LifeSciences Holdings, Inc. (aktie - 0.1159%) Arcutis Biotherapeutics (aktie - 0.114%) AnaptysBio, Inc. (aktie - 0.1128%) Enliven Therapeutics, Inc. (aktie - 0.1058%) Vir Biotechnology, Inc. (aktie - 0.1033%) Cullinan Oncology, Inc. (aktie - 0.1015%) Evolus, Inc. (aktie - 0.1005%) Relay Therapeutics, Inc. (aktie - 0.0971%) Sana Biotechnology, Inc. (aktie - 0.0919%) Tango Therapeutics, Inc. (aktie - 0.086%) PetIQ, Inc. (aktie - 0.0856%) Castle Biosciences, Inc. (aktie - 0.0854%) 89bio, Inc. (aktie - 0.0842%) Erasca, Inc. (aktie - 0.0792%) ORIC Pharmaceuticals, Inc. (aktie - 0.0755%) Olema Pharmaceuticals, Inc. (aktie - 0.074%) Arbutus Biopharma Corporation (aktie - 0.0736%) Scholar Rock Holding Corporation (aktie - 0.0726%) Replimune Group, Inc. (aktie - 0.0723%) Savara Inc. (aktie - 0.0717%) Pliant Therapeutics, Inc. (aktie - 0.0707%) Adaptive Biotechnologies Corporation (aktie - 0.0695%) Terns Pharmaceuticals, Inc. (aktie - 0.0687%) Ironwood Pharmaceuticals, Inc. (aktie - 0.0663%) Pacira BioSciences, Inc. (aktie - 0.0643%) Tourmaline Bio, Inc. (aktie - 0.0605%) Y-mAbs Therapeutics, Inc. (aktie - 0.0604%) SIGA Technologies, Inc. (aktie - 0.0603%) Humacyte, Inc. (aktie - 0.0601%) 4D Molecular Therapeutics, Inc. (aktie - 0.0597%) Revance Therapeutics, Inc. (aktie - 0.0589%) Lexicon Pharmaceuticals, Inc. (aktie - 0.0582%) Allogene Therapeutics (aktie - 0.0567%) Alector, Inc. (aktie - 0.0566%) Mineralys Therapeutics, Inc. (aktie - 0.0564%) REGENXBIO (aktie - 0.0559%) UroGen Pharma Ltd. (aktie - 0.0553%) ACELYRIN, INC. Common Stock (aktie - 0.0541%) Arcturus Therapeutics Holdings Inc. (aktie - 0.0541%) OmniAb, Inc. (aktie - 0.0505%) Anavex Life Sciences Corp. (aktie - 0.0475%) Pacific Biosciences of California, Inc. (aktie - 0.0475%) EyePoint Pharmaceuticals, Inc. (aktie - 0.0466%) Taysha Gene Therapies, Inc. (aktie - 0.045%) KalVista Pharmaceuticals, Inc. (aktie - 0.0448%) Prime Medicine, Inc. (aktie - 0.0446%) Sage Therapeutics, Inc. (aktie - 0.0431%) iTeos Therapeutics, Inc. (aktie - 0.0426%) GRAIL, LLC (aktie - 0.042%) Phibro Animal Health Corporation (aktie - 0.0412%) Xeris Pharmaceuticals, Inc. (aktie - 0.041%) MaxCyte, Inc. (aktie - 0.0407%) Verve Therapeutics, Inc. (aktie - 0.0407%) Nautilus Biotechnology, Inc. (aktie - 0.0402%) Lyell Immunopharma, Inc. (aktie - 0.0383%) Voyager Therapeutics, Inc. (aktie - 0.0345%) MeiraGTx Holdings plc (aktie - 0.0314%) Biomea Fusion, Inc. (aktie - 0.0302%) Editas Medicine, Inc. (aktie - 0.0287%) Atea Pharmaceuticals, Inc. (aktie - 0.0285%) Vanda Pharmaceuticals (aktie - 0.0276%) Zentalis Pharmaceuticals, Inc. (aktie - 0.0275%) Precigen, Inc. (aktie - 0.0257%) Cabaletta Bio, Inc. (aktie - 0.022%) Fulcrum Therapeutics, Inc. (aktie - 0.0209%) Amylyx Pharmaceuticals (aktie - 0.0194%) MacroGenics, Inc. (aktie - 0.0188%) Caribou Biosciences, Inc. (aktie - 0.0175%) Ventyx Biosciences, Inc. (aktie - 0.0163%) 23andMe Holding Co. (aktie - 0.0119%) ALX Oncology Holdings Inc. (aktie - 0.0109%) Coherus BioSciences, Inc. (aktie - 0.0106%) Marinus Pharmaceuticals, Inc. (aktie - 0.0084%) Bluebird Bio (aktie - 0.0082%) Aclaris Therapeutics, Inc. (aktie - 0.0075%) Ovid Therapeutics Inc. (aktie - 0.0075%) Reneo Pharmaceuticals, Inc. (aktie - 0.0059%) RAPT Therapeutics, Inc. (aktie - 0.0057%)
United Kingdom	8	AstraZeneca PLC (aktie - 4.43%) Roivant Sciences Ltd. (aktie - 0.8579%) Verona Pharma plc (aktie - 0.21%) Immunocore Holdings plc (aktie - 0.125%) Centessa Pharmaceuticals Limited (aktie - 0.1137%) Bicycle Therapeutics plc (aktie - 0.0914%) Autolus Therapeutics plc (aktie - 0.0722%) Exscientia Holdings Limited (aktie - 0.0252%)
Netherlands	3	argenx SE (aktie - 1.66%) Merus N.V. (aktie - 0.3288%) uniQure (aktie - 0.0227%)
France	1	Sanofi (aktie - 1.63%)
Germany	3	BioNTech SE (aktie - 1.07%) CureVac N.V. (aktie - 0.0712%) Atai Life Sciences N.V. (aktie - 0.0219%)
China	2	BeiGene, Ltd. (aktie - 0.8671%) Zai Lab Limited (aktie - 0.1091%)
Denmark	2	Ascendis Pharma A/S (aktie - 0.8501%) Genmab A/S (aktie - 0.1027%)
Ireland	5	Jazz Pharmaceuticals plc (aktie - 0.6636%) Alkermes plc (aktie - 0.4561%) Avadel Pharmaceuticals plc (aktie - 0.1249%) Prothena Corporation plc (aktie - 0.112%) Amarin (aktie - 0.024%)
Switzerland	2	CRISPR Therapeutics AG (aktie - 0.4018%) AC Immune SA (aktie - 0.0342%)
Canada	4	Xenon Pharmaceuticals Inc. (aktie - 0.294%) Aurinia Pharmaceuticals Inc. (aktie - 0.1014%) Zymeworks Inc. (aktie - 0.0914%) AbCellera Biologics Inc. (aktie - 0.0751%)
Jersey	1	NovoCure Limited (aktie - 0.1822%)
Spain	1	Grifols, S.A. (aktie - 0.1067%)
Bermuda	1	Kiniksa Pharmaceuticals, Ltd. (aktie - 0.1009%)
Singapore	1	Wave Life Sciences Ltd. (aktie - 0.0677%)
Belgium	1	Galapagos NV (aktie - 0.0588%)
Hong Kong	1	Hutchison China MediTech Limited (aktie - 0.0518%)
Cayman Islands	1	Theravance Biopharma, Inc. (aktie - 0.0367%)

Bezahlen Sie Ihr Abonnement

Weitere Funktionen und Daten zur Unternehmens- und Portfolioanalyse sind im Abonnement verfügbar

Abonnieren

Aktie

Werkzeuge

Gemeinschaft

Kontakte

2025 © Investing Port
Kontakte | Werbung
Die Verwendung von porti.ru-Materialien ist nur zulässig, wenn ein aktiver indizierter Link zur Quelle vorhanden ist.